EU approves NewAmsterdam and Menarini's obicetrapib drugs
Go back to EU approves NewAmsterdam and Menarini's obicetrapib drugs| NAMSCO Corporation (NASDAQ: NAMS) | Delayed: 21.58 +0.32 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.26 | 52 Week High | $0.00 | |||
| Open | $21.25 | 52 Week Low | $0.00 | |||
| Day High | $21.79 | P/E | N/A | |||
| Day Low | $21.02 | EPS | $0.00 | |||
| Volume | 1,265,985 | |||||



